IDF-3rd WAS Conference
IDF Conference - 3rd WAS Family Conference, 2015
The Wiskott-Aldrich Foundation is pleased to announce the 3rd International WAS Families and Researchers Conference from June 25-27, 2015 in New Orleans, U.S.A. All WAS families and patients are encouraged to attend to hear from the experts and share experiences. The 2nd WAS Family Conference was held in Baltimore in 2013. It was a great success and there was overwhelming request for a 3rd conference.
The conference is jointly sponsored by the Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation.
Why attend: This is a wonderful opportunity for WAS families to gather in a non-medical setting to:
- Hear from WAS experts in immunology, transplant, hematology and gene therapy from around the world, have their questions answered and concerns addressed.
- Learn more about the latest therapies (including Gene Therapy) and hear about the breakthroughs that are being made
- Share experiences with other families and for the children to meet other children and siblings of WAS families.
- Great opportunity for the family to have fun visiting New Orleans.
Hyatt Regency, New Orleans,
601 Loyola Avenue
New Orleans, LA 70113, USA
When: Thursday, June 25- to Saturday 27, 2015
WAS Specific Session*: Noon, Thursday, June 25 to 5 PM, Friday, June 26.*
General Sessions: Saturday, June 27. Connect with other families facing Primary Immune Deficiency and hear about a range of issues from Genetic Counseling, Families Facing Chronic illness, School & Insurance Concerns and more!
- What is WAS? Spectrum of Clinical Manifestations and Diagnosis
- Pathophysiology of WAS.
- The WAS gene and how it affects WBC, platelets, basics on T and B cells
- Treatment of WAS – Options, Decision Making for Patients with different Clinical Severity
- Hematopoietic Stem Cell Transplant – Current state, Outcome, Complications, Practical notions
- HSCT – Long term outcome, QOL, complications, what to watch for, follow up routine, sterility and its preservation – Future directions,
- Gene therapy: efficacy and toxicity
- QOL for WAS patients
- Autoimmunity, relationship to cancer, management
- Prevention and Treatment of Bleeding Complications (Splenectomy, Eltrombopag, Romiplostim, Amicar, NovoSeven, platelet transfusion recommendations),
- Management of Eczema and Other Dermatologic Manifestations
- IL 2 Therapy: Preliminary Results
- Alessandro Aiuti, M.D., PhD.
- James Bussel, M.D.
- Fabio Candotti, M.D.
- Alain Fischer, M.D., PhD.
- Luigi Notarangelo, M.D.
- Hans Ochs, M.D.
- Jordan Orange, M.D., Ph.D.
- Joie Davis, PNP-BC, APNG
- Deborah Tamura, M.S., R.N.
Early Registration: Registration is now open. Early Registration Deadline is on or before April 30th. To register, please go to Registration
Regular Registration: April 30 - June 6. To Register, please go to Registration
Scholarships: Limited number of need based partial scholarships based on financial need are available through are available through IDF . if you would like to apply for a scholarship to cover the hotel costs for the nights of the 25th, 26th and 27th, please go to IDF Scholarship The deadline for the Scholarship Application is March 21.
Limited number of partial scholarships based on financial need are available through the Wiskott-Aldrich Foundation on a first-come, first served basis. If you would like to apply for a scholarship to cover the cost of registration, child care and or to cover travel costs, please go to Wiskott-Aldrich Foundation Scholarship, enter your e mail address. An application will be e mailed to you.
Questions? Contact one of the conference organizers below.
- Dr. Fabio Candotti, M.D., University de Lausanne, Switzerland
- Kathy Antilla: Immune Deficiency Foundation
- Robin Wenzel: Wiskott-Aldrich Foundation firstname.lastname@example.org
- Paige Hill: Wiskott-Aldrich Foundation
- Amir Kedar: Israeli WAS Association
- Sumathi Iyengar, M.D., Wiskott-Aldrich Foundation email@example.com +1 919 641 7134
* Agenda, times etc are subject to change